Log in to save to my catalogue

Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A m...

Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A m...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c74b6eb4bb804da1a30ee465a6c75054

Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real‐world study

Publication information

Publisher

United States: John Wiley & Sons, Inc

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Background
Lymphoid neoplasms treatment has recently been renewed to increase antitumor efficacy and conventional chemotherapies toxicities. Limited data have been published about the infection risk associated with these new drugs, therefore this study analyzes the infectious complications in patients with lymphoproliferative diseases (LPD) trea...

Alternative Titles

Full title

Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real‐world study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_c74b6eb4bb804da1a30ee465a6c75054

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c74b6eb4bb804da1a30ee465a6c75054

Other Identifiers

ISSN

2045-7634

E-ISSN

2045-7634

DOI

10.1002/cam4.4293

How to access this item